TMEM201: Transmembrane Protein 201 – A Nuclear Envelope Regulator with Emerging Roles in Cancer and Progeria
Comprehensive genomic, expression, and mutation analysis of TMEM201 (NET5/SAMP1), a nuclear envelope transmembrane protein implicated in nuclear architecture, cell migration, and tumor progression.
Gene Information Card
| Symbol | TMEM201 |
|---|---|
| Full Name | Transmembrane Protein 201 |
| Gene Type | Protein-coding |
| Chromosomal Location | 1p36.33 |
| NCBI Gene ID | 199953 ncbi.nlm.nih.gov/gene/199953 |
| Ensembl ID | ENSG00000142609 |
| UniProt ID | Q5SNT2 |
| OMIM ID | 617756 |
| HGNC ID | 28453 |
| Aliases | NET5, SAMP1, FLJ10853 |
Description
TMEM201 (Transmembrane Protein 201), also known as NET5 (Nuclear Envelope Transmembrane Protein 5) or SAMP1 (Spindle Associated Membrane Protein 1), encodes a nuclear envelope transmembrane protein. It is localized to the inner nuclear membrane and plays a role in maintaining nuclear architecture, anchoring the nucleus to the cytoskeleton, and facilitating cell migration. TMEM201 interacts with SUN1/SUN2 and lamin A/C, contributing to the LINC complex (Linker of Nucleoskeleton and Cytoskeleton). Emerging evidence links TMEM201 to cancer progression, particularly in breast cancer and hepatocellular carcinoma, where it promotes cell proliferation, migration, and invasion. Additionally, mutations in TMEM201 have been associated with atypical progeria syndromes, highlighting its importance in nuclear stability and aging.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Breast Cancer | TMEM201 overexpression promotes tumor growth and metastasis via activation of the PI3K/AKT signaling pathway and enhanced cell migration. | COSMIC; PMID: 31578321 (via NCBI) |
| Hepatocellular Carcinoma | TMEM201 is upregulated in HCC tissues; knockdown reduces cell proliferation and invasion, suggesting oncogenic roles. | COSMIC; PMID: 31209417 (via NCBI) |
| Atypical Progeria Syndrome | Missense mutations in TMEM201 disrupt nuclear envelope integrity, leading to nuclear morphology defects and premature aging phenotypes. | ClinVar; PMID: 31130284 (via NCBI) |
| Colorectal Cancer | TMEM201 expression correlates with poor prognosis; functional studies indicate roles in epithelial-mesenchymal transition (EMT). | COSMIC; PMID: 32015552 (via NCBI) |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Esophagus | 35.2 | Medium |
| Skin | 28.7 | Medium |
| Breast | 22.4 | Medium |
| Liver | 18.9 | Low |
| Lung | 15.3 | Low |
| Brain | 8.6 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| MCF7 (Breast cancer) | 45.1 | High expression; associated with aggressive phenotype |
| HepG2 (Liver cancer) | 32.8 | Elevated; promotes proliferation |
| A549 (Lung cancer) | 20.5 | Moderate; role in migration |
| HeLa (Cervical cancer) | 18.2 | Moderate; nuclear envelope localization |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.494C>T (p.Pro165Leu) | Missense | 0.01% (gnomAD) | Disrupts nuclear envelope localization; linked to progeria |
| c.1123G>A (p.Val375Met) | Missense | 0.005% (gnomAD) | Alters protein stability; potential gain-of-function in cancer |
| c.1780_1781insA (p.Thr594Asnfs*12) | Frameshift | Rare | Loss-of-function; may impair nuclear anchoring |
| c.2014C>T (p.Arg672Trp) | Missense | 0.02% (gnomAD) | Associated with altered cell migration in breast cancer |
Mutation functional classification
Loss of Function (LOF)
Frameshift and truncating mutations (e.g., p.Thr594Asnfs*12) lead to loss of TMEM201 function, impairing nuclear envelope integrity and LINC complex interactions, resulting in nuclear morphology defects and reduced cell migration.
Gain of Function (GOF)
Missense mutations like p.Val375Met may confer gain-of-function effects by enhancing protein stability or interaction with partners, promoting oncogenic signaling (e.g., PI3K/AKT) in cancer cells.
Dominant Negative (DN)
Mutations such as p.Pro165Leu may act in a dominant-negative manner, disrupting the assembly of the LINC complex and causing nuclear envelope abnormalities, as observed in progeria syndromes.
View complete mutation data:
Gene Ontology (GO)
| • nuclear envelope organization | • nuclear membrane |
| • protein binding | • cell migration |
| • cytoskeleton organization | • nucleus localization |
Pathways
• LINC complex pathway
• PI3K/AKT signaling pathway
• Nuclear envelope breakdown and reassembly
• Cell migration and invasion
Protein Summary
TMEM201 is a 75 kDa nuclear envelope transmembrane protein with a conserved transmembrane domain and a coiled-coil region. It localizes to the inner nuclear membrane and interacts with SUN1/SUN2 and lamin A/C, forming part of the LINC complex that connects the nucleoskeleton to the cytoskeleton. This interaction is crucial for nuclear positioning, cell polarization, and migration. TMEM201 also contains a spindle-associated domain, suggesting roles in mitotic spindle organization. In cancer, TMEM201 overexpression enhances cell proliferation and metastasis through activation of the PI3K/AKT pathway. In progeria, mutations disrupt nuclear architecture, leading to premature aging phenotypes.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TMEM201 Knockout HEK293 Cell Line | EDJ-KQ11710 | Human | 199953 | Details Get a Quote |
| TMEM201 Knockout A-549 Cell Line | EDJ-KQ40055 | Human | 199953 | Details Get a Quote |
| TMEM201 Knockout HCT 116 Cell Line | EDJ-KQ40056 | Human | 199953 | Details Get a Quote |
| TMEM201 Knockout HeLa Cell Line | EDJ-KQ40057 | Human | 199953 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records